INSTITUT GUSTAVE ROUSSY;UNIVERSITE PARIS-SUD XI;VIROXIS S.A.S.;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
发明人:
Thierry Heidmann
申请号：
US14896505
公开号：
US09974852B2
申请日:
2014.06.06
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A pharmaceutical composition includes, as active substance a mutated non-primate lentiviral Env protein having decreased immunosuppressive properties, substantially no immunosuppressive properties or no immunosuppressive properties, or a variant of the mutated lentiviral Env protein, or a fragment of the above proteins, in association with a pharmaceutically acceptable carrier.
